A.M. Schmidt
Impact in
- Clinical Biochemistry top 0.1%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Advanced Glycation End Products research 4
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- J Brett (4 shared papers)D Stern (4 shared papers)J Kao (3 shared papers)Matthias Clauss (3 shared papers)J Ryan (3 shared papers)Rong Cao (2 shared papers)Shi‐Fang Yan (1 shared paper)Jill P. Crandall (1 shared paper)
- Journals
- Blood (2 papers)Journal of Clinical Investigation (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United States
In The Last Decade
A.M. Schmidt
6 papers receiving 2.1k citations
A.M. Schmidt's Hit Papers
Peers
Comparison fields: 5 of 89
- Clinical Biochemistry 1.3k
- Endocrinology, Diabetes and Metabolism 592
- Neurology 187
- Nephrology 147
- Immunology and Allergy 82
Countries citing papers authored by A.M. Schmidt
This map shows the geographic impact of A.M. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Schmidt more than expected).
Fields of papers citing papers by A.M. Schmidt
This network shows the impact of papers produced by A.M. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Schmidt. The network helps show where A.M. Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside A.M. Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. Hit paper breakdown → | 1995 | 785 |
| 2 | Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. Hit paper breakdown → | 1992 | 730 |
| 3 | 1993 | 267 | |
| 4 | 1993 | 146 | |
| 5 | 1993 | 118 | |
| 6 | 1994 | 108 |
About A.M. Schmidt
A.M. Schmidt is a scholar working on Clinical Biochemistry, Molecular Biology, Hematology, Nutrition and Dietetics and Genetics, having authored 6 papers that have together received 2.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Cell Adhesion Molecules Research (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Diabetes and associated disorders (2 papers), Natural Antidiabetic Agents Studies (1 paper), Fatty Acid Research and Health (1 paper) and Child Nutrition and Water Access (1 paper). The work is most often cited by research in Clinical Biochemistry (1.3k citations), Endocrinology, Diabetes and Metabolism (592 citations), Neurology (187 citations), Nephrology (147 citations) and Immunology and Allergy (82 citations). A.M. Schmidt has collaborated with scholars based in United States. Frequent co-authors include J Brett, D Stern, J Kao, Matthias Clauss, J Ryan, Rong Cao, Shi‐Fang Yan, Jill P. Crandall, J X Chen and Jian Zhang. Their work appears in journals such as Blood, Journal of Clinical Investigation and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.